Angiotensin-converting enzyme inhibition alters the fibrinolytic response to cardiopulmonary bypass. Pretorius M, Murphey LJ, McFarlane JA, Vaughan DE, Brown NJ (2003) Circulation 108: 3079-83 Angiotensin-converting enzyme inhibition increases human vascular tissue-type plasminogen activator release through endogenous bradykinin. Pretorius M, Rosenbaum D, Vaughan DE, Brown NJ (2003) Circulation 107: 579-85 Fibrinolysis is essential for fracture repair and prevention of heterotopic ossification. Yuasa M, Mignemi NA, Nyman JS, Duvall CL, Schwartz HS, Okawa A, Yoshii T, Bhattacharjee G, Zhao C, Bible JE, Obremskey WT, Flick MJ, Degen JL, Barnett JV, Cates JM, Schoenecker JG (2015) J Clin Invest 125: 3117-31 The Vasculature in Prediabetes. Wasserman DH, Wang TJ, Brown NJ (2018) Circ Res 122: 1135-1150 Uncoupling fibrin from integrin receptors hastens fibrinolysis at the platelet-fibrin interface. Braaten JV, Jerome WG, Hantgan RR (1994) Blood 83: 982-93 Plasminogen activator inhibitor-1 secretion of endothelial cells increases fibrinolytic resistance of an in vitro fibrin clot: evidence for a key role of endothelial cells in thrombolytic resistance. Handt S, Jerome WG, Tietze L, Hantgan RR (1996) Blood 87: 4204-13 Regulation of fibrinolysis by platelet-released plasminogen activator inhibitor 1: light scattering and ultrastructural examination of lysis of a model platelet-fibrin thrombus. Braaten JV, Handt S, Jerome WG, Kirkpatrick J, Lewis JC, Hantgan RR (1993) Blood 81: 1290-9 No effect of clot age or thrombolysis on argatroban's inhibition of thrombin. Hantgan RR, Jerome WG, Hursting MJ (1998) Blood 92: 2064-74 Endogenous bradykinin contributes to increased plasminogen activator inhibitor 1 antigen following hemodialysis. Marney AM, Ma J, Luther JM, Ikizler TA, Brown NJ (2009) J Am Soc Nephrol 20: 2246-52 Effects of Acute and Antecedent Hypoglycemia on Endothelial Function and Markers of Atherothrombotic Balance in Healthy Humans. Joy NG, Tate DB, Younk LM, Davis SN (2015) Diabetes 64: 2571-80 Effect of combination glipizide GITS/metformin on fibrinolytic and metabolic parameters in poorly controlled type 2 diabetic subjects. Cefalu WT, Schneider DJ, Carlson HE, Migdal P, Gan Lim L, Izon MP, Kapoor A, Bell-Farrow A, Terry JG, Sobel BE (2002) Diabetes Care 25: 2123-8 Effect of activation and inhibition of the renin-angiotensin system on plasma PAI-1. Brown NJ, Agirbasli MA, Williams GH, Litchfield WR, Vaughan DE (1998) Hypertension 32: 965-71 Differing effects of mineralocorticoid receptor-dependent and -independent potassium-sparing diuretics on fibrinolytic balance. Ma J, Albornoz F, Yu C, Byrne DW, Vaughan DE, Brown NJ (2005) Hypertension 46: 313-20 Comparative effect of angiotensin-converting enzyme inhibition and angiotensin II type 1 receptor antagonism on plasma fibrinolytic balance in humans. Brown NJ, Agirbasli M, Vaughan DE (1999) Hypertension 34: 285-90 Bradykinin stimulates tissue plasminogen activator release in human vasculature. Brown NJ, Gainer JV, Stein CM, Vaughan DE (1999) Hypertension 33: 1431-5 Endogenous NO regulates plasminogen activator inhibitor-1 during angiotensin-converting enzyme inhibition. Brown NJ, Muldowney JA, Vaughan DE (2006) Hypertension 47: 441-8 Contribution of endogenous bradykinin to fibrinolysis, inflammation, and blood product transfusion following cardiac surgery: a randomized clinical trial. Balaguer JM, Yu C, Byrne JG, Ball SK, Petracek MR, Brown NJ, Pretorius M (2013) Clin Pharmacol Ther 93: 326-34 Angiotensin-converting enzyme inhibition and smoking potentiate the kinin response to cardiopulmonary bypass. Pretorius M, McFarlane JA, Vaughan DE, Brown NJ, Murphey LJ (2004) Clin Pharmacol Ther 76: 379-87 A pilot study indicating that bradykinin B2 receptor antagonism attenuates protamine-related hypotension after cardiopulmonary bypass. Pretorius M, Scholl FG, McFarlane JA, Murphey LJ, Brown NJ (2005) Clin Pharmacol Ther 78: 477-85 Comparative effects of angiotensin receptor blockade and ACE inhibition on the fibrinolytic and inflammatory responses to cardiopulmonary bypass. Billings FT, Balaguer JM, C Y, Wright P, Petracek MR, Byrne JG, Brown NJ, Pretorius M (2012) Clin Pharmacol Ther 91: 1065-73 Transport time and care processes for patients transferred with ST-segment-elevation myocardial infarction: the reperfusion in acute myocardial infarction in Carolina emergency rooms experience. Muñoz D, Roettig ML, Monk L, Al-Khalidi H, Jollis JG, Granger CB (2012) Circ Cardiovasc Interv 5: 555-62 Spironolactone abolishes the relationship between aldosterone and plasminogen activator inhibitor-1 in humans. Sawathiparnich P, Kumar S, Vaughan DE, Brown NJ (2002) J Clin Endocrinol Metab 87: 448-52 Markedly impaired fibrinolytic balance contributes to cardiovascular risk in adults with growth hormone deficiency. Devin JK, Blevins LS, Verity DK, Chen Q, Bloodworth JR, Covington J, Vaughan DE (2007) J Clin Endocrinol Metab 92: 3633-9 Effect of combined AT1 receptor and aldosterone receptor antagonism on plasminogen activator inhibitor-1. Sawathiparnich P, Murphey LJ, Kumar S, Vaughan DE, Brown NJ (2003) J Clin Endocrinol Metab 88: 3867-73 Treatment with Sildenafil Improves Insulin Sensitivity in Prediabetes: A Randomized, Controlled Trial. Ramirez CE, Nian H, Yu C, Gamboa JL, Luther JM, Brown NJ, Shibao CA (2015) J Clin Endocrinol Metab 100: 4533-40 Interactive effect of PAI-1 4G/5G genotype and salt intake on PAI-1 antigen. Brown NJ, Murphey LJ, Srikuma N, Koschachuhanan N, Williams GH, Vaughan DE (2001) Arterioscler Thromb Vasc Biol 21: 1071-7 Plasmin Prevents Dystrophic Calcification After Muscle Injury. Mignemi NA, Yuasa M, Baker CE, Moore SN, Ihejirika RC, Oelsner WK, Wallace CS, Yoshii T, Okawa A, Revenko AS, MacLeod AR, Bhattacharjee G, Barnett JV, Schwartz HS, Degen JL, Flick MJ, Cates JM, Schoenecker JG (2017) J Bone Miner Res 32: 294-308 Platelets and endothelial cells act in concert to delay thrombolysis--evidence from an in vitro model of the human occlusive thrombus. Hantgan RR, Jerome WG, Handt S (1998) Thromb Haemost 79: 602-8 Degradation products of fibrinogen and fibrin in bacteremia due to gram-negative rods. Satterwhite TK, Hawiger J, Burklow SL, Koenig MG (1973) J Infect Dis 127: 437-41 Monitoring activity of fibrinolytic agents. A therapeutic challenge. Shafer KE, Santoro SA, Sobel BE, Jaffe AS (1984) Am J Med 76: 879-86 Skizzle is a novel plasminogen- and plasmin-binding protein from Streptococcus agalactiae that targets proteins of human fibrinolysis to promote plasmin generation. Wiles KG, Panizzi P, Kroh HK, Bock PE (2010) J Biol Chem 285: 21153-64 Male-female differences in the genetic regulation of t-PA and PAI-1 levels in a Ghanaian population. Schoenhard JA, Asselbergs FW, Poku KA, Stocki SA, Gordon S, Vaughan DE, Brown NJ, Moore JH, Williams SM (2008) Hum Genet 124: 479-88 Interactions of exercise, coagulation, platelets, and fibrinolysis--a brief review. Bourey RE, Santoro SA (1988) Med Sci Sports Exerc 20: 439-46 Bradykinin and its metabolite bradykinin 1-5 inhibit thrombin-induced platelet aggregation in humans. Murphey LJ, Malave HA, Petro J, Biaggioni I, Byrne DW, Vaughan DE, Luther JM, Pretorius M, Brown NJ (2006) J Pharmacol Exp Ther 318: 1287-92 Cross-sectional relations of multiple biomarkers representing distinct biological pathways to plasma markers of collagen metabolism in the community. Joseph J, Pencina MJ, Wang TJ, Hayes L, Tofler GH, Jacques P, Selhub J, Levy D, D'Agostino RB, Benjamin EJ, Vasan RS (2009) J Hypertens 27: 1317-24 The coagulation cascade in sepsis. Wang L, Bastarache JA, Ware LB (2008) Curr Pharm Des 14: 1860-9 Formation and regulation of platelet and fibrin hemostatic plug. Hawiger J (1987) Hum Pathol 18: 111-22 The renin-angiotensin-aldosterone system and fibrinolysis in progressive renal disease. Brown NJ, Vaughan DE, Fogo AB (2002) Semin Nephrol 22: 399-406 Endothelial cells organize fibrin clots into structures that are more resistant to lysis. Jerome WG, Handt S, Hantgan RR (2005) Microsc Microanal 11: 268-77 Angiotensin-converting enzyme inhibition alters the inflammatory and fibrinolytic response to cardiopulmonary bypass in children. Fleming GA, Billings FT, Klein TM, Bichell DP, Christian KG, Pretorius M (2011) Pediatr Crit Care Med 12: 532-8
Hints: (1) double-click or double-tap to navigate to a node. (2) Grab a node and move it to arrange the graph.